Taste receptor type 2 member 31 (TAS2R31) is a G protein-coupled receptor (GPCR) that belongs to the TAS2R bitter taste receptor family. In humans and primates, TAS2R31 is implicated in detecting bitter compounds, including saccharin and acesulfame potassium, and has extraoral roles in airway smooth muscle relaxation . The recombinant form of this receptor, derived from Pan paniscus (bonobo), enables functional and structural studies to elucidate its ligand specificity, signaling mechanisms, and evolutionary significance.
TAS2R31 is a seven-transmembrane domain receptor typical of GPCRs. Key structural features include:
Transmembrane domains (TMs): Critical for ligand binding and signal transduction.
Extracellular loops (ECLs): Involved in agonist recognition .
N-terminal domain: Plays a role in receptor trafficking and ligand specificity .
TAS2R31 responds to diverse agonists, including:
Acesulfame potassium (bitterness perception linked to polymorphisms) .
Aristolochic acid (selective activation via chimeric receptor studies) .
Mutagenesis studies highlight residues in TM7 and intracellular loops as critical for agonist selectivity. For example, swapping residues between TAS2R31 and TAS2R46 inverted ligand specificity .
Acesulfame Potassium Sensitivity: Specific SNPs (e.g., R35W, D45H) in TAS2R31 correlate with perceived bitterness intensity .
Bronchodilation: TAS2R31 activation in airway smooth muscle increases intracellular Ca²⁺, triggering potassium channel opening and muscle relaxation .
Comparative analyses of TAS2R genes in Pan paniscus and humans reveal:
Subspecies-Specific Haplotypes: ~66% of TAS2R haplotypes in chimpanzees are unique to subspecies, driven by dietary adaptations .
Purifying Selection: Dominates in eastern chimpanzees (P. t. schweinfurthii), contrasting with balancing selection in western populations .
Recombinant TAS2R31 is utilized in:
Bitter Compound Screening: Identifies agonists/antagonists for food and pharmaceutical industries .
Bronchial Studies: Mechanistic insights into TAS2R31-mediated airway relaxation for asthma therapeutics .
Genetic Association Studies: Links polymorphisms to taste perception and dietary preferences .
| Feature | Pan paniscus TAS2R31 | Human TAS2R31 |
|---|---|---|
| Ligand Specificity | Saccharin, aristolochic acid | Saccharin, acesulfame K |
| Expression | Airway smooth muscle | Taste buds, gut |
| Key Polymorphisms | R35W (functional) | D45H (bitter perception) |
| Structural Homology | 89% amino acid identity | Reference sequence |
TAS2R31 (Taste receptor type 2 member 31) is a G protein-coupled receptor (GPCR) encoded by the TAS2R31 gene that functions primarily as a bitter taste receptor. In Pan paniscus, as in other primates, this receptor is part of the broader TAS2R family responsible for detecting bitter compounds. The receptor is structurally similar to other sensory receptors including opsins and olfactory receptors .
TAS2R31 has been extensively documented to respond to saccharin in vitro, serving as a key mediator in bitter taste perception . The receptor's primary function involves initiating transduction cascades upon agonist binding, which ultimately generates neural signals interpreted as bitter taste . While the evolutionary distance between Pan paniscus and humans is small, subtle species-specific differences in receptor structure may affect ligand binding profiles and sensitivity thresholds.
Recombinant Pan paniscus TAS2R31 protein production generally follows protocols similar to those used for Pan troglodytes. The standard production method involves:
Gene synthesis or cloning of the full-length TAS2R31 coding sequence (1-309 amino acids)
Insertion into an expression vector with an N-terminal His-tag
Expression in bacterial systems such as E. coli
Protein purification via affinity chromatography
For optimal experimental utility, the following storage and reconstitution methods are recommended:
| Parameter | Recommended Conditions |
|---|---|
| Storage | -20°C to -80°C |
| Buffer | Tris/PBS-based buffer with 6% Trehalose, pH 8.0 |
| Reconstitution | Deionized sterile water to 0.1-1.0 mg/mL |
| Long-term storage | Add 5-50% glycerol (50% recommended) and aliquot |
| Stability | Avoid repeated freeze-thaw cycles |
Methodologically, researchers should centrifuge vials before opening and prepare working aliquots that can be stored at 4°C for up to one week to maintain protein integrity .
TAS2R31 is a transmembrane receptor with several key structural features that influence its function:
Transmembrane domains: The protein contains multiple transmembrane regions that anchor it to the cell membrane of taste receptor cells and other tissues where it's expressed.
Binding pocket: Contains specific residues that interact with bitter compounds. Notably, position 35 (R35W substitution) has been identified as functionally significant in TAS2R31, dramatically affecting receptor responses to compounds like saccharin and acesulfame potassium .
Signal transduction regions: The cytoplasmic domains interact with G proteins to initiate downstream signaling events, triggering calcium ion influx and subsequent cell depolarization .
These structural features collectively determine receptor sensitivity, specificity, and signaling efficiency when exposed to bitter compounds.
Polymorphisms in TAS2R31 significantly impact receptor function, necessitating careful experimental design. While human TAS2R31 polymorphisms have been well-characterized, Pan paniscus variations have received less attention but likely follow similar functional patterns.
The R35W substitution represents one of the most functionally significant polymorphisms identified in TAS2R31, with strong effects on receptor function and direct associations with taste responses to bitter off-tastes of saccharin and acesulfame potassium . Other substitutions, such as D45H, demonstrate more complex conditional effects, altering receptor function only when combined with specific alleles (e.g., the W35 allele) .
When designing experiments with Pan paniscus TAS2R31:
Genotyping: Researchers should sequence the full TAS2R31 coding region from their Pan paniscus samples to identify polymorphisms before functional studies.
Haplotype analysis: Consider examining complete haplotypes rather than individual SNPs, as functional effects often result from combined substitutions.
Comparative approaches: Include human and Pan troglodytes TAS2R31 variants as references in functional assays to contextualize Pan paniscus-specific findings.
Heterologous expression systems: When using cell-based assays, carefully select expression systems that minimize interference with receptor trafficking and signaling.
Dose-response relationships: Polymorphisms may alter EC50 values rather than completely abolishing function, necessitating full dose-response curves rather than single-concentration experiments.
This polymorphic complexity underscores the need for comprehensive genetic characterization prior to functional studies to avoid confounding experimental results .
Studying TAS2R31 activation requires sophisticated methodological approaches depending on the cellular context:
Calcium imaging: Measures intracellular calcium mobilization following receptor activation using fluorescent indicators (Fura-2, Fluo-4).
Patch-clamp electrophysiology: Records membrane potential changes directly from individual cells.
FLIPR-based assays: High-throughput screening of multiple compounds using fluorescence plate readers.
Tissue-specific reporter systems: Custom constructs with tissue-specific promoters driving expression of TAS2R31 coupled to luminescent or fluorescent reporters.
Ex vivo tissue preparations: Organ bath studies measuring smooth muscle tension in airway tissue expressing TAS2R31.
Immunohistochemistry combined with functional assays: Co-localization of TAS2R31 with functional readouts in tissue slices.
Bioluminescence resonance energy transfer (BRET): Measures protein-protein interactions between TAS2R31 and signaling partners.
Surface plasmon resonance (SPR): Quantifies direct binding of ligands to purified receptor.
Molecular dynamics simulations: Computationally predicts binding pocket interactions with potential ligands.
Researchers should carefully select methodologies based on their specific research questions, as each approach offers different advantages in sensitivity, throughput, and physiological relevance .
TAS2R31 has significant extraoral functions beyond its canonical role in taste perception, with important implications for comparative primate physiology:
TAS2R31 expression in airway smooth muscle contributes to bronchodilation through a distinct molecular mechanism. When activated, these receptors trigger increased intracellular calcium, which subsequently opens potassium channels, hyperpolarizing the membrane and causing smooth muscle relaxation . This mechanism may represent an evolutionary adaptation for detecting and responding to inhaled irritants or pathogens.
In intestinal tissue, TAS2R activation triggers:
Release of antimicrobial peptides (α-defensin 5, REG3A)
Regulation of other innate immune factors including mucins and chemokines
A comprehensive RNA-Seq analysis revealed that TAS2R activation (with denatonium benzoate) induces:
TAS2Rs in gut tissues influence:
Endocrine responses to bitter compounds
Gastric emptying rates
Potential monitoring of quorum sensing in intestinal flora
When designing studies examining these extraoral functions in Pan paniscus, researchers should consider tissue-specific expression patterns and signaling pathways that may differ from those in taste cells. Comparative studies with human and Pan troglodytes tissues may reveal species-specific adaptations in these non-gustatory roles .
Selecting appropriate experimental systems for assessing Pan paniscus TAS2R31 function requires careful consideration of multiple factors:
| System | Advantages | Limitations | Best Applications |
|---|---|---|---|
| HEK293T cells | High transfection efficiency, robust growth | Limited G-protein repertoire | High-throughput screening, mutation analysis |
| CHO cells | Stable expression, minimal endogenous GPCR signaling | More challenging transfection | Long-term stable cell lines, complex signaling studies |
| Sf9 insect cells | High protein yield, proper folding of GPCRs | Glycosylation differences from mammals | Protein purification, structural studies |
Calcium mobilization assays: Most widely used for TAS2R functional characterization, utilizing calcium-sensitive dyes (Fura-2, Fluo-4) to measure receptor activation. These provide real-time, quantitative measurements of receptor function.
Inositol phosphate (IP) accumulation: Measures downstream signaling events following receptor activation, providing complementary data to calcium assays.
MAPK phosphorylation: Evaluates activation of mitogen-activated protein kinase pathways, relevant for extraoral TAS2R31 functions.
Receptor internalization assays: Utilizes fluorescently tagged receptors to monitor trafficking following activation, providing insights into desensitization mechanisms.
Co-expression of appropriate G-proteins (typically Gα16gust44) to enhance coupling efficiency
Inclusion of positive controls (known agonists like saccharin) and negative controls
Dose-response analysis across physiologically relevant concentration ranges
Maximization of signal-to-noise ratio through optimization of cell density and expression levels
The most robust experimental approach combines multiple assay systems to provide convergent evidence of receptor function, particularly when characterizing novel ligands or receptor variants .
Membrane proteins like TAS2R31 present significant technical challenges for researchers. Here are methodological approaches to address common issues:
Poor surface expression:
Utilize N-terminal epitope tags rather than C-terminal tags
Include rhodopsin-derived N-terminal signal sequences
Optimize codon usage for expression system
Consider using inducible expression systems to reduce toxicity
Protein misfolding:
Incorporate chemical chaperones in culture media (e.g., DMSO, glycerol)
Lower incubation temperature during expression (28-30°C)
Co-express with molecular chaperones
Receptor degradation:
Add proteasome inhibitors during expression
Create fusion constructs with stable protein domains
Optimize detergent selection for membrane extraction
Functional verification:
Employ multiple orthogonal assays (calcium imaging, BRET, receptor internalization)
Include well-characterized control receptors in parallel experiments
Validate with known agonists before testing novel compounds
Structural analysis:
Consider nanobody stabilization approaches
Utilize cryo-electron microscopy for structural determination
Apply molecular dynamics simulations to predict conformational changes
Binding studies:
Implement thermostabilized receptor variants for ligand binding assays
Use fragment-based screening approaches for identifying binding sites
Develop fluorescently labeled ligands for direct binding measurements
These methodological refinements can substantially improve the quality and reliability of data obtained from recombinant TAS2R31 studies, enabling more accurate characterization of this challenging membrane protein .
TAS2R31 variations provide unique insights into primate evolution and adaptation:
The TAS2R31 gene harbors extensive polymorphism across hominids, including numerous nonsynonymous variants that affect receptor function . This genetic diversity suggests that TAS2R31 has been subject to diverse selective pressures throughout primate evolution, potentially related to:
Dietary adaptations: Different bitter compound profiles in available food sources
Toxin avoidance mechanisms: Species-specific sensitivity to environmental toxins
Extraoral functions: Variations in immune and respiratory responses
When conducting evolutionary studies of Pan paniscus TAS2R31:
Sequence comparison methodology:
Align full coding sequences from Pan paniscus, Pan troglodytes, Homo sapiens, and other primates
Calculate dN/dS ratios to identify regions under positive or purifying selection
Perform ancestral sequence reconstruction to trace evolutionary trajectory
Functional divergence assessment:
Test receptor responses to a standardized panel of bitter compounds
Compare EC50 values and maximal responses across species variants
Identify species-specific ligands that may reflect ecological adaptations
Population genetics analysis:
Evaluate allele frequencies within and between populations
Test for signatures of selective sweeps or balancing selection
Compare haplotype structures across hominid species
| Evolutionary Scenario | Supporting Evidence | Research Approach |
|---|---|---|
| Dietary specialization | Species-specific receptor sensitivities | Cross-species functional testing with ecological relevant compounds |
| Pathogen defense adaptation | Differential expression in respiratory/gut tissues | Comparative immunological challenge studies |
| Relaxed selection in certain lineages | Accumulation of function-altering polymorphisms | Population genetics and molecular clock analyses |
These evolutionary perspectives can provide critical context for understanding the functional significance of observed variations in Pan paniscus TAS2R31, connecting molecular mechanisms to adaptive outcomes .
Robust experimental controls are essential for generating reliable data when working with recombinant Pan paniscus TAS2R31:
Known agonists: Include saccharin and acesulfame potassium as established TAS2R31 activators
Species-matched controls: Include well-characterized Pan paniscus receptors from the same family
Expression verification: Implement anti-tag antibody detection to confirm protein expression
Non-transfected cells: Essential for establishing baseline responses
Inactive receptor mutants: Generate site-directed mutants with altered binding sites
Non-ligand compounds: Include structurally related compounds known not to activate TAS2R31
Signal transduction verification: Include positive controls for calcium flux (e.g., ATP, ionomycin)
Cell viability assessment: Monitor potential cytotoxicity of test compounds
Receptor specificity confirmation: Test compounds against related TAS2R family members
| Control Type | Implementation | Expected Outcome | Troubleshooting |
|---|---|---|---|
| Expression level | Western blot/flow cytometry | Consistent protein levels between experiments | Adjust transfection conditions if variable |
| Functional capacity | Dose-response to saccharin | EC50 within expected range | Re-clone or verify sequence if abnormal |
| System stability | Repeated measurements over time | Consistent baseline and maximum responses | Optimize cell culture conditions if unstable |
| Specificity verification | Testing on non-target receptors | No/minimal cross-reactivity | Refine compound selection if non-specific |
Implementing these methodological controls ensures that observed effects can be confidently attributed to Pan paniscus TAS2R31 activity rather than experimental artifacts or system-specific phenomena .
Integrating computational and experimental approaches creates powerful synergies in TAS2R31 research:
Homology Modeling and Molecular Docking:
Generate 3D structural models of Pan paniscus TAS2R31 based on related GPCRs
Predict binding sites for candidate compounds
Experimental validation: Test predicted high-affinity ligands in cellular assays
Iterative refinement: Use experimental binding data to improve computational models
Molecular Dynamics Simulations:
Simulate receptor conformational changes upon ligand binding
Predict effects of amino acid substitutions on protein stability
Experimental application: Guide site-directed mutagenesis experiments to target functionally critical residues
Validation approach: Compare simulation-predicted stability changes with thermal stability assays
Machine Learning for Ligand Prediction:
Train models on known TAS2R ligand datasets to predict new compounds
Identify structural features associated with receptor activation
Experimental implementation: Screen computationally prioritized compounds
Feedback loop: Update models with new experimental data
Translating in vitro findings about TAS2R31 to physiologically relevant in vivo contexts presents significant challenges that researchers must address methodically:
Concentration Discrepancies:
Challenge: In vitro systems often use concentrations exceeding physiological levels
Solution: Establish dose-response relationships spanning physiological ranges
Validation approach: Measure actual compound concentrations in relevant tissues (e.g., taste buds, airways, intestine)
Receptor Expression Differences:
Challenge: Heterologous systems typically overexpress receptors compared to native tissues
Solution: Develop controlled expression systems matching physiological levels
Measurement technique: Quantitative PCR and western blotting to compare expression levels
Signaling Environment Complexity:
Challenge: In vivo systems contain complete signaling cascades not present in simplified models
Solution: Reconstitute key signaling components in vitro
Validation: Compare calcium signals in cell lines vs. primary taste cells or tissue slices
Tissue-Specific Effects:
Challenge: TAS2R31 functions differently in taste buds versus extraoral tissues
Solution: Study receptor in tissue-specific contexts
Methodological approach: Develop tissue-specific conditional expression models
| Research Phase | Methodologies | Validation Approaches | Expected Outcomes |
|---|---|---|---|
| In vitro screening | Cell-based assays, purified protein studies | Dose-response relationships, receptor specificity | Initial compound identification, structure-activity relationships |
| Ex vivo validation | Tissue explants, primary cell cultures | Tissue-specific responses, physiological concentrations | Confirmation in more complex systems, pathway identification |
| In vivo confirmation | Animal models, human subject studies | Behavioral responses, physiological measurements | Translation to organism-level effects, clinical relevance |
For Pan paniscus TAS2R31 specifically, this translational challenge is compounded by ethical and practical limitations in conducting in vivo studies. Researchers may need to rely more heavily on comparative approaches, using insights from human and other primate models, alongside carefully designed ex vivo systems from available tissue samples .
TAS2R31 research provides a valuable window into primate sensory evolution through several methodological approaches:
Pan paniscus TAS2R31 can be analyzed within the broader context of primate evolution by:
Phylogenetic analysis: Constructing gene trees to trace TAS2R31 evolution across primates, identifying:
Gene duplication events
Lineage-specific selection pressures
Rates of evolutionary change
Selection signature detection: Applying statistical tests (dN/dS ratios, McDonald-Kreitman tests) to identify:
Positively selected sites potentially involved in adaptation
Conserved regions essential for basic receptor function
Relaxed selection in specific lineages
Haplotype diversity assessment: Comparing polymorphism patterns between Pan paniscus, Pan troglodytes, and humans to detect:
Species-specific selective sweeps
Shared ancestral polymorphisms
Evidence of convergent evolution
To link genetic changes to adaptive phenotypes:
Ancestral sequence reconstruction: Recreating and testing ancestral TAS2R31 variants to track functional changes over evolutionary time
Ecological correlation studies: Connecting receptor variations to dietary specializations across primate species
Positive selection hotspot identification: Focusing on regions with accelerated evolution for functional testing
The extensive polymorphism in TAS2R31 across populations suggests this receptor has been subject to diverse selective pressures throughout primate evolution, potentially related to:
Species-specific food preference adaptations
Geographic variation in available bitter compounds
The discovery of TAS2R31 expression in extraoral tissues has significant implications for therapeutic development and disease research:
TAS2R31 activation in airway smooth muscle leads to bronchodilation through calcium-dependent mechanisms and potassium channel activation . This physiological response suggests:
Therapeutic potential: TAS2R31 agonists could represent novel bronchodilators for asthma and COPD treatment
Research approaches:
Screening selective TAS2R31 agonists with limited taste effects
Testing species-specific responses in primate airway models
Investigating signaling pathway differences between taste and airway tissues
TAS2R activation in intestinal tissues triggers:
Antimicrobial peptide release: α-defensin 5 and REG3A production
Innate immune modulation: Regulation of mucins and chemokines affecting bacterial growth
Metabolic signaling: Endocrine responses and gastric emptying regulation
TAS2R31 variations have been linked to:
Respiratory infections: TAS2R polymorphisms associate with susceptibility to respiratory pathogens
Metabolic regulation: Variations associate with glucose regulation
Immune response modulation: TAS2R activation triggers NRF2-mediated stress responses
| Research Phase | Approaches | Considerations for Pan paniscus TAS2R31 |
|---|---|---|
| Target validation | Expression analysis in disease-relevant tissues | Compare expression patterns with human tissues |
| Compound screening | High-throughput functional assays | Test species-specific response profiles |
| Lead optimization | Structure-activity relationship studies | Consider receptor polymorphisms |
| Delivery development | Tissue-targeted formulations | Develop methods that limit taste effects |
| Safety assessment | Off-target screening | Evaluate cross-reactivity with other TAS2Rs |
These extraoral functions position TAS2R31 as a promising target for treating conditions involving innate immune dysregulation, respiratory diseases, and potentially metabolic disorders .
Emerging technologies offer unprecedented opportunities to advance TAS2R31 research:
Recent advances in cryo-EM resolution now enable structural determination of challenging membrane proteins like GPCRs:
Methodological advantages:
Does not require protein crystallization
Can capture multiple conformational states
Allows visualization of protein-ligand complexes
TAS2R31-specific applications:
Determine high-resolution structures of Pan paniscus TAS2R31
Compare agonist-bound versus unbound conformations
Identify structural differences between primate TAS2R31 variants
Precise genetic manipulation enables:
Functional genomics approaches:
Generate isogenic cell lines with specific TAS2R31 variants
Create humanized or "bonobo-ized" receptor variants to study species differences
Establish knock-in/knockout models for physiological studies
Regulatory element analysis:
Identify and modify TAS2R31 expression control elements
Study tissue-specific regulation mechanisms
Investigate epigenetic regulation patterns
These methods reveal cell-type specific patterns:
Single-cell RNA sequencing (scRNA-seq):
Map TAS2R31 expression across diverse cell populations
Identify co-expressed signaling components
Discover novel cell types expressing TAS2R31
Single-cell proteomics:
Quantify receptor protein levels at single-cell resolution
Correlate expression with functional responses
Map post-translational modifications
Three-dimensional tissue models enable:
Physiologically relevant testing:
Generate taste bud organoids expressing TAS2R31
Create airway and intestinal organoids for extraoral function studies
Develop species-specific organoids to compare Pan paniscus versus human responses
Disease modeling:
Study receptor function in patient-derived organoids
Model genetic variation effects in controlled environments
Test compound responses in complex tissue architectures
These technologies collectively promise to transform our understanding of TAS2R31 from isolated receptor studies to integrated physiological contexts, particularly valuable for comparative studies between human and non-human primate variants .
Despite significant advances in TAS2R research, several critical knowledge gaps remain specific to Pan paniscus TAS2R31:
Sequence and Polymorphism Characterization:
Limited genomic data on Pan paniscus TAS2R31 variants compared to humans
Insufficient population-level sequence data to assess diversity
Incomplete understanding of species-specific polymorphisms
Functional Characterization:
Few direct functional studies of Pan paniscus TAS2R31
Limited knowledge of species-specific ligand responsiveness
Unclear extraoral expression patterns compared to humans and chimpanzees
Evolutionary Context:
Incomplete understanding of selective pressures on Pan paniscus TAS2R31
Limited data on dietary correlates with receptor variations
Insufficient comparative data across closely related species
| Priority Area | Key Questions | Methodological Approaches | Expected Impact |
|---|---|---|---|
| Genetic Diversity | What is the extent of TAS2R31 polymorphism in Pan paniscus populations? | Whole-genome sequencing, targeted resequencing | Establish baseline for evolutionary and functional studies |
| Functional Profiling | How does Pan paniscus TAS2R31 differ functionally from human and Pan troglodytes variants? | Heterologous expression, calcium imaging, comparative pharmacology | Define species-specific response profiles |
| Extraoral Functions | What is the expression pattern and function of TAS2R31 in Pan paniscus extraoral tissues? | Tissue-specific RNA-Seq, immunohistochemistry, ex vivo functional assays | Understand potential physiological roles beyond taste |
| Evolutionary Analysis | What selective forces have shaped TAS2R31 in Pan paniscus? | Comparative genomics, selection analysis, ecological correlation studies | Determine evolutionary significance of observed variations |
| Structural Biology | What structural features differentiate Pan paniscus TAS2R31? | Homology modeling, cryo-EM, molecular dynamics simulations | Identify molecular basis for functional differences |
Addressing these gaps requires collaborative approaches combining:
Field work to collect genomic samples from diverse Pan paniscus populations
Comparative experimental approaches using standardized methodologies across species
Interdisciplinary integration of molecular, ecological, and evolutionary perspectives
Prioritizing these research areas will establish a comprehensive understanding of Pan paniscus TAS2R31, bridging current knowledge gaps and providing valuable comparative insights into primate sensory evolution .